By Yi Liu, PharmD, PhD, PCCA Research Pharmacist

PCCA never stops initiating and working with others on a variety of research projects, keeping up with the cutting-edge compounding technology, sharing evidence-based knowledge, and turning innovative ideas into practice. PCCA Science is here not only to present the scientific research conducted by our very own Research and Development, Formulation Development and Clinical Services teams, but also to support PCCA member pharmacies in preparing and publishing their clinical findings, ultimately to promote our profession and meet more patients’ needs.

Currently, PCCA has ongoing research activities at different levels ranging from cell biology to patient studies. We combine knowledge from basic, foundational science all the way to advanced clinical practice. To that end, we are inviting PCCA members to work with us: Tell us about your patient’s story, your plan for a potential study or even your innovative idea. PCCA Science will work with you to translate it into a scientific publication to spread the benefits to more patients while promoting your practice. Contact us at pccascience@pccarx.com.

Check our PCCA Science webpage often and stay tuned to our latest publications on PCCA products, compounded therapies and case studies. Here are recent publications:

Recent Publications

Pediatric Compounding Pharmacy: Taking on the Responsibility of Providing Quality Customized Prescriptions
Journal article by PCCA, published in Children (May 2019). Read the full text here.

Compounded Gabapentin for Neuropathic Pain: Stability and Beyond-Use Date (BUD) in Some Commonly Used Bases
Journal article by independent researchers using PCCA’s base Lipoderm^®, published in the Journal of the American Pharmacists Association (July-August 2019). Read the abstract here.

Veterinary: Feline Patient Treated with Transdermal Gabapentin
Case study by a veterinary practice, published by PCCA Science. Read it here.

In Vitro Evaluation of Naltrexone HCl 1% Topical Cream in XemaTop for Psoriasis
Conference poster and abstract by PCCA, presented at the Society for Investigative Dermatology 77th Annual Meeting in Chicago, Illinois, May 8–11, 2019. Access the poster here and the conference abstract (#691) here.

Yi Liu, PharmD, PhD, is a research pharmacist in the Research and Development department at PCCA. She joined PCCA as a clinical pharmacy researcher in the Clinical Services department in 2018 and started her current role in 2019. Yi graduated from Ohio University with a PhD in molecular and cellular biology in 2012. She also worked as a postdoctoral research fellow in the Houston Methodist Research Institute for three years prior to starting pharmacy school. Yi received her PharmD from the University of Houston College of Pharmacy in 2019.